Institutional investors purchased a net $4.8 million shares of SPPI during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 87.18% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 1.7 Million shares of Spectrum Pharmaceuticals ...